| EPB0287 | COVID-19 breakthroughs among people with HIV in South Carolina | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0286 | Serological responses to primary course and booster SARS-CoV2 vaccination in people with HIV: the SCAPE-HIV study | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0285 | Adaptation of HIV care, support and treatment (CST) services during COVID-19 pandemic in Indonesia | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0284 | Low CD4 T-cell count further attenuates immunogenicity of COVID-19 vaccines in people with HIV: a systematic review and meta-analysis | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0283 | Influence of SARS-COV-2 on coagulation and cardiovascular plasma biomarkers in people living with HIV | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0282 | Post-acute sequelae of COVID-19 (PASC) and Quality of Life in people with HIV | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0281 | Sex and sexually transmitted diseases in time of COVID: sexual behavior and incidence of gonorrhea and chlamydia in an HIV observational cohort in Thailand | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0280 | Assessing the Infection Prevention and Control Program during the COVID-19 era in the Health Facilities Participating in the COVIV (COVID/HIV) National Study in Mozambique, 2021-2022 | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0279 | Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in persons living with HIV (PLWH): Immunogenicity comparative analysis between one dose and two doses of Ad5-nCoV vaccine | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0278 | Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in persons living with HIV (PLWH): safety and immunogenicity analysis | E-poster | SARS-CoV-2, COVID-19 and HIV |